ARC’s unique combination of targeted support services, brings together a deep understanding of global in vitro diagnostic research regulation, streamlined laboratory testing and advanced digital technologies to deliver high-quality, GCP compliant patient screening in precision medicine clinical trials.
When your clinical trial depends on biomarker screening - country-specific requirements, lab readiness and study responsibilities must align. Having a clear view of the full Dx picture is critical in meeting your trial and organisational goals.
ARC’s 15 years of specialist expertise have shaped our clinical development support services. Having contributed to more than 150+ precision medicine clinical trials, we understand the challenges of multi-stakeholder research and use that experience to anticipate and resolve issues as they arise.
FROM First in-human TO PIVOTAL REGISTRATIONAL TRIALS
Tell us your trial phase, regulatory challenge or operational need, and our team will help identify the right place to start.
Who We Partner With
ARC works with specialist organisations across diagnostics, laboratory services and precision medicine to support complex clinical programmes.
Our Approach
Specialist support that connects requirements,responsibilities and delivery, helping your team make informed decisions asyour programme progresses.
Understand the IVD/CDx activities your study needs, howrequirements differ between countries and where they affect your plans.
Define responsibilities across delegated activities andmaintain visibility of submissions, test sites and study progress.
Work with specialists who connect diagnostic requirementswith the practical needs of your clinical programme.
Discover more expert perspectives, industry updates, and practical guidance from the ARC team.
The ARC team welcomes the opportunity to connect with you, share our real-life experiences and help navigate your business as you find kinder patient treatments.
.png)
.png)
